These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19505410)

  • 1. Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.
    Cantarini L; Tinazzi I; Caramaschi P; Bellisai F; Brogna A; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(2):551-5. PubMed ID: 19505410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.
    Watanabe S; Aizawa-Yashiro T; Tsuruga K; Kinjo M; Ito E; Tanaka H
    Rheumatol Int; 2013 Dec; 33(12):3105-8. PubMed ID: 23266507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
    Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
    J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept in the treatment of intestinal Behcet's disease.
    Ma D; Zhang CJ; Wang RP; Wang L; Yang H
    Cell Biochem Biophys; 2014 Jul; 69(3):735-9. PubMed ID: 24622940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The short-term efficacy and safety treatment study of recurrent uveitis in Behcet disease with etanercept].
    Zhang MF; Zhao C; Wen X; Du H; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):145-50. PubMed ID: 20388349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent oral aphthous ulcers with etanercept.
    Scheinberg MA
    Clin Exp Rheumatol; 2002; 20(5):733-4. PubMed ID: 12412213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-TNF alpha agents in vasculitis].
    Solans Laqué R; Bosch Gil JA
    Med Clin (Barc); 2008 Feb; 130(3):93-4. PubMed ID: 18261379
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
    Arida A; Fragiadaki K; Giavri E; Sfikakis PP
    Semin Arthritis Rheum; 2011 Aug; 41(1):61-70. PubMed ID: 21168186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
    Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren syndrome in a child: favorable response of the arthritis to TNFalpha blockade.
    Pessler F; Monash B; Rettig P; Forbes B; Kreiger PA; Cron RQ
    Clin Rheumatol; 2006 Sep; 25(5):746-8. PubMed ID: 16391885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
    Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
    Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile generalized pustular psoriasis treated with etanercept.
    Fialová J; Vojáčková N; Vaňousová D; Hercogová J
    Dermatol Ther; 2014; 27(2):105-8. PubMed ID: 24703268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of vascular Behçet's disease.
    Alibaz-Oner F; Direskeneli H
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():105-108. PubMed ID: 29665281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.
    Alty JE; Monaghan TM; Bamford JM
    Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.